STRATEGIC REPORT GOVERNANCE FINANCIAL STATEMENTS SHAREHOLDER INFORMATION Financial highlights Contents STRATEGIC REPORT REVENUE 3.4% OPERATING CASH FLOW BEFORE 1 Financial highlights EXCEPTIONAL ITEMS AND TAX 1.5% 2 At a glance 6 E xecutive Chairmans statement 884.8m 166.7m 8 C hief Executive Officers Q&A 2014: 856.0 million 2014: 164.2 million 14 Our healthcare world 2015 884.8m 2015 166.7m 16 Our business model 2014 164.2m 18 Our strategy 2014 856.0m 20 K ey performance indicators 2013 764.5m 2013 111.2m 26 Financial review 2012 738.9m 34 Clinical review 2011 674.0m 38 Operating review 42 Our people 46 C orporate social responsibility PATIENT DISCHARGES 3.7% ADJUSTED BASIC EARNINGS PER SHARE 48 R isk management and IN-PATIENT AND DAYCASE 2.2% internal control 50 Principal risks 270.0k 18.3p GOVERNANCE 2014: 260.3k 2014: 17.9p 58 Our Board of Directors 60 T he senior leadership team 2015 270.0k 2015 18.3p 62 C hairmans governance 2014 2014 260.3k 17.9p letter 63 Corporate governance 2013 236.2k 68 A udit and Risk Committee 2012 232.6k Report 2011 223.1k 72 C linical Governance and Safety Committee Report 74 Nomination Committee Report ADJUSTED EBITDA 2.2% PROFIT FOR THE YEAR 76 D irectors Remuneration Report 94 Directors Report 160.1m 60.0m 97 S tatement of Directors 2014: 156.7 million 2014: 6.0 million responsibilities 2015 160.1m 2015 60.0m FINANCIAL STATEMENTS 2014 156.7m 2014 6.0m 98 I ndependent Auditors 2013 150.0m Report 106 C onsolidated financial 2012 statements 111 N otes to the financial OPERATING PROFIT BEFORE PROPOSED FINAL DIVIDEND PER SHARE statements EXCEPTIONAL ITEMS -2.5% 33.3% 137 P arent Company financial statements 111.2m 2.4p SHAREHOLDER INFORMATION 2014: 114.1 million 2014: 1.8p 144 A dditional shareholder information 2015 111.2m 2015 2.4p 146 Glossary 2014 114.1m 2014 1.8p 148 I mportant information: forward-looking 2013 111.1m statements Operating profit, adjusted to add back depreciation and exceptional items, referred to hereafter as Adjusted EBITDA 2014 EBITDA adjusted to conform the property rental base and PLC operating costs base.
Operating cash flow adjusted to add back the cash flow effect of exceptional items and income tax.
Calculated as pro-forma profit after tax divided by the number of ordinary shares in issue.
For 2014, pro-forma profit is calculated as earnings after tax adjusted for the capital restructuring, exceptional items, to conform the property rental base, PLC operating costs and the net profit arising on the sale of property and other assets detailed on page 32.
Spire Healthcare Group plc Annual Report 2015 1
